CUR Health Sciences Division Announces 2021 Mentor Awardees

The Health Sciences Division of the Council on Undergraduate Research announces the 2021 recipients of its Mentor Awards, which honor exceptional mentoring and advising by higher education faculty across all subdivisions of health sciences.

Read more

Nanoparticles Help Untangle Alzheimer’s Disease Amyloid Beta Plaques

ROCKVILLE, MD – Scientists are still a long way from being able to treat Alzheimer’s Disease, in part because the protein aggregates that can become brain plaques, a hallmark of the disease, are hard to study.

Read more

NeuroVision Imaging Inc., Announces New Funding From the ADDF to Develop Affordable, Accessible Biomarkers to Diagnose Alzheimer’s and Related Dementias

NeuroVision Imaging Inc., announced today it has received an investment from the Alzheimer’s Drug Discovery Foundation (ADDF) to support developing reliable, affordable biomarker tests for Alzheimer’s disease and other forms of dementia and neurodegenerative disorders.

Read more

Coconut Oil’s Benefits to Alzheimer’s Ignored in N.Y. Times Attack, Says Dr. Leslie Norins of MCI911.com

Although cardiologists often decry coconut oil because of certain fats it contains, they overlook the growing evidence that other fatty constituents, especially medium-chain triglycerides, may alleviate some cases of mild cognitive impairment and Alzheimer’s disease

Read more

How Caregivers of People with Dementia Can Navigate Holidays During the Pandemic

As COVID-19 cases increase across the nation, many caregivers are trying to navigate the holidays for relatives with dementia or Alzheimer’s disease. The Centers for Disease Control and Prevention suggests that people not travel to limit the potential spread of the coronavirus.

Mary Catherine Lundquist, program director of Care2Caregivers, a peer counseling helpline (800-424-2494) for caregivers of people with dementia and Alzheimer’s disease operated by Rutgers Behavioral Health Care, discusses how families can stay connected with their loved ones.

Read more

Researchers Discover Neuroprotective Treatment for Chronic Traumatic Brain Injury

Traumatic brain injury (TBI) is a leading cause of cognitive impairment that affects millions of people worldwide. Despite growing awareness about the debilitating and lifelong progressive consequences of TBI, there are currently no treatments that slow the deteriorative process. TBI survivors are currently treated with extensive physical and cognitive rehabilitation, accompanied by medications that may mitigate symptoms yet do not halt or slow neurodegeneration. Now, researchers have found for the first time that this process can be pharmacologically reversed in an animal model of this chronic health condition, offering an important proof of principle in the field and a potential path to new therapy.

Read more

Virginia Tech scientists advance understanding of blood-brain barrier health

in a study with potential impacts on a variety of neurological diseases, Virginia Tech researchers have provided the first experimental evidence from a living organism to show that an abundant, star-shaped brain cell known as an astrocyte is essential for blood-brain barrier health.

Read more

What Factors Help Predict Who Will Keep Their Memory into Their 90s?

Why do some people stay sharp into their 90s, even if they have the amyloid plaques in the brain that are associated with Alzheimer’s disease? And why do others reach their 90s without ever developing any plaques? These questions are explored in a new study published in the July 22, 2020, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Read more

Blood Vessel Defects in Eyes May Foretell Alzheimer’s

Alzheimer’s disease in its early stages affects the integrity of small blood vessels in the retinas of patients, according to a recent study led by Cedars-Sinai. This discovery holds promise for early diagnosis of Alzheimer’s through the retina, a back-of-the-eye organ that is an extension of the brain and easily accessible for live, noninvasive imaging.

Read more

How to Help Loved Ones with Dementia Cope During COVID-19

The COVID-19 pandemic and resulting social isolation present unique challenges for more than five million Americans living with Alzheimer’s disease and their caregivers. Monica Townsend, training and consultation specialist at the Comprehensive Services on Aging at Rutgers University Behavioral Health Care, shares how caregivers can cope through the health crisis:

Read more

Upended Caregiving Impact for 5M+ Americans with Alzheimer’s, Caregivers

The COVID-19 pandemic is presenting unique challenges for 5M+ Americans living with Alzheimer’s and their caregivers. The recent upending of traditional caregiving resources and structures, across home, adult day services, residential and assisted living facilities and nursing homes, has created new challenges for caregivers. Data from the Alzheimer’s Association indicates 48% of nursing home residents are living with Alzheimer’s or other dementias and among older adults in residential care settings, including assisted living, 42% or more have some form of dementia. Still others receive community-based services, including 32% of individuals using home health services and 31% using adult day services.

The Alzheimer’s Association continues to offer free care and support for families through 24/7 Helpline (800.272.3900) staffed by clinical experts, while local support groups are now being offered via virtual channels for the foreseeable future. Experts including Harry Johns, president

Read more

Primary Care Physicians on the Front Lines of Diagnosing and Providing Alzheimer’s and Dementia Care: Half Say Medical Profession Not Prepared to Meet Expected Increase in Demands

– Report provides latest Alzheimer’s prevalence, incidence, mortality and costs of care data –
– Barring medical breakthroughs, the number of people age 65+ with Alzheimer’s dementia may nearly triple by 2050 –

Read more

AI-analyzed blood test can predict the progression of neurodegenerative disease

Evaluating the effectiveness of therapies for neurodegenerative diseases is often difficult because each patient’s progression is different. A new study shows artificial intelligence (AI) analysis of blood samples can predict and explain disease progression, which could one day help doctors choose more appropriate and effective treatments for patients.

Read more

IU School of Medicine awarded $36 million NIH grant for Alzheimer’s disease drug discovery center

The IU-led center is one of only two multi-institution teams in the nation selected as part of a new federal program intended to improve, diversify and reinvigorate the Alzheimer’s disease drug development pipeline.

Read more